{"id":1854,"date":"2017-06-14T02:18:17","date_gmt":"2017-06-14T02:18:17","guid":{"rendered":"https:\/\/follistatin-peptide.com\/vyhody-follistatinu\/"},"modified":"2025-04-28T13:15:59","modified_gmt":"2025-04-28T13:15:59","slug":"vyhody-follistatinu","status":"publish","type":"page","link":"https:\/\/follistatin-peptide.com\/cs\/vyhody-follistatinu\/","title":{"rendered":"V\u00fdhody follistatinu"},"content":{"rendered":"
[et_pb_section fb_built=“1″ background_image=“https:\/\/follistatin-peptide.com\/wp-content\/uploads\/2017\/06\/homebg2.jpg“ fullwidth=“on“ admin_label=“Section“ custom_css_main_element=“background-position:100% 0;“][et_pb_fullwidth_header title=“V\u00fdhody follistatinu“ text_orientation=“center“ title_font_color=“#ffffff“ admin_label=“Fullwidth Header“ title_font_size=“50px“ title_font_size_phone=“25px“ title_font_size_last_edited=“on|desktop“ custom_css_title=“ padding-bottom: 100px;“][\/et_pb_fullwidth_header][\/et_pb_section][et_pb_section fb_built=“1″ background_color=“rgba(255,255,255,0)“ inner_shadow=“on“ admin_label=“Section“][et_pb_row use_custom_width=“on“ custom_padding=“|3%||3%“ custom_margin=“-150px|||“ background_color=“#ffffff“ parallax_method_1=“off“ parallax_method_2=“off“ admin_label=“\u0158\u00e1dek“ custom_css_main_element=“ z-index: 999;|| border-top: 20px solid #696a6d;“][et_pb_column type=“3_4″ parallax=“off“ parallax_method=“off“][et_pb_code admin_label=“V\u0161e, co pot\u0159ebujete v\u011bd\u011bt“]<dl class=“window-body orange“><!– [et_pb_line_break_holder] –> <dt>V\u0161e, co pot\u0159ebujete v\u011bd\u011bt o follistatinu<\/dt><!– [et_pb_line_break_holder] –> <dd><!– [et_pb_line_break_holder] –> V pr\u016fb\u011bhu t\u00e9to \u010d\u00e1sti v\u00e1m poskytneme v\u0161echny informace, kter\u00e9 byste mohli pot\u0159ebovat, pokud jde o teoretick\u00e9 v\u00fdhody pou\u017e\u00edv\u00e1n\u00ed follistatinu, zn\u00e1m\u00e9 nebo p\u0159edpokl\u00e1dan\u00e9 vedlej\u0161\u00ed \u00fa\u010dinky, kolik je t\u0159eba vz\u00edt pro \u00fa\u010dinnou d\u00e1vku a dokonce i to, jak ji p\u0159ipravit k injekci.<!– [et_pb_line_break_holder] –> <\/dd><!– [et_pb_line_break_holder] –><\/dl>[\/et_pb_code][et_pb_text admin_label=“Follistatin Benefits“ module_class=“card card-primary“ text_text_color=“#000000″]<\/p>\n
Zat\u00edmco ji\u017e v\u00edme, \u017ee integrace follistatinu m\u016f\u017ee v\u00e9st k masivn\u00edmu r\u016fstu sval\u016f, o dal\u0161\u00edch pozitivn\u00edch v\u00fdhod\u00e1ch, kter\u00e9 m\u016f\u017ee u\u017eivatel\u016fm nab\u00eddnout, toho v\u00edme mnohem m\u00e9n\u011b.<\/p>\n
Jedna studie<\/a> z roku 2008 uk\u00e1zala pozitivn\u00ed v\u00fdsledky, pokud jde o zm\u00edrn\u011bn\u00ed nebo dokonce potenci\u00e1ln\u00ed zvr\u00e1cen\u00ed spin\u00e1ln\u00ed atrofie u my\u0161\u00ed. Tento stav, zn\u00e1m\u00fd jako „SMA“ (spin\u00e1ln\u00ed svalov\u00e1 atrofie), nast\u00e1v\u00e1, kdy\u017e postupn\u011b odum\u00edraj\u00ed spin\u00e1ln\u00ed motorick\u00e9 neurony, co\u017e vede k regresi (atrofii) p\u0159ipojen\u00fdch spin\u00e1ln\u00edch sval\u016f. <\/p>\n To m\u016f\u017ee v\u00e9st k v\u00e1\u017en\u00e9mu zhor\u0161en\u00ed pohyblivosti a v nejhor\u0161\u00edm p\u0159\u00edpad\u011b k \u00fapln\u00e9 z\u00e1vislosti u\u017eivatele na invalidn\u00edm voz\u00edku.<\/p>\n U my\u0161\u00ed bylo p\u0159i l\u00e9\u010db\u011b follistatinem pozorov\u00e1no prodlou\u017een\u00ed d\u00e9lky \u017eivota a\u017e o 30 % ve spojen\u00ed s v\u00fdrazn\u00fdm zlep\u0161en\u00edm svalstva, pohyblivosti a struktur\u00e1ln\u00ed integrity.<\/p>\n L\u00e9\u010dba tohoto onemocn\u011bn\u00ed je proto nyn\u00ed hlavn\u00edm bodem mezi sou\u010dasn\u00fdmi testy prov\u00e1d\u011bn\u00fdmi na lidech v nad\u011bji, \u017ee l\u00e9\u010dba follistatinem m\u016f\u017ee b\u00fdt schopna poslat ho do regrese.<\/p>\n [\/et_pb_text][et_pb_code admin_label=“obr\u00e1zek v\u00fdhod“]<ul class=“benefits“><!– [et_pb_line_break_holder] –> <li><img src=“https:\/\/follistatin-peptide.com\/wp-content\/uploads\/2017\/06\/c3.jpg“ alt=““ \/><\/li><!– [et_pb_line_break_holder] –> <li><img src=“https:\/\/follistatin-peptide.com\/wp-content\/uploads\/2017\/06\/c22.jpg“ alt=““ \/><\/li><!– [et_pb_line_break_holder] –> <li><img src=“https:\/\/follistatin-peptide.com\/wp-content\/uploads\/2017\/06\/c4.jpg“ alt=““ \/><\/li><!– [et_pb_line_break_holder] –> <li><img src=“https:\/\/follistatin-peptide.com\/wp-content\/uploads\/2017\/06\/c11.jpg“ alt=““ \/><\/li><!– [et_pb_line_break_holder] –><\/ul><!– [et_pb_line_break_holder] –>[\/et_pb_code][et_pb_code disabled_on=“on|on|on“ admin_label=“text“ disabled=“on“]<div class=“card card-primary“><!– [et_pb_line_break_holder] –><h3 style=“color:white;“>\u00daloha myostatinu v t\u011ble<\/h3><!– [et_pb_line_break_holder] –><p>Myostatin je regula\u010dn\u00ed r\u016fstov\u00fd faktor, kter\u00fd v kone\u010dn\u00e9m d\u016fsledku omezuje mno\u017estv\u00ed svalov\u00e9 hmoty, kterou je t\u011blo schopno vytvo\u0159it. Jako takov\u00fd je asi pom\u011brn\u011b snadn\u00e9 pochopit, pro\u010d se ka\u017ed\u00fd, kdo m\u00e1 estetick\u00e9 c\u00edle, sna\u017e\u00ed jeho p\u0159\u00edtomnost sn\u00ed\u017eit. <\/p><p><!– [et_pb_line_break_holder] –>Zn\u00e1m\u00fd tak\u00e9 jako GDF8 (Growth And Differentiation Factor 8); myostatin za\u010d\u00edn\u00e1 pracovat v ran\u00e9m embryon\u00e1ln\u00edm st\u00e1diu na\u0161eho v\u00fdvoje a pokra\u010duje v kontrole na\u0161eho svalstva po cel\u00fd n\u00e1\u0161 dosp\u011bl\u00fd \u017eivot.<\/p><p><!– [et_pb_line_break_holder] –>Je to gen MTSN, kter\u00fd nakonec obsahuje „instrukce“, jimi\u017e se t\u011blo mus\u00ed \u0159\u00eddit, aby mohlo produkovat myostatin a v\u0161echny ostatn\u00ed \u010dleny „rodiny“ r\u016fstov\u00fdch a diferencia\u010dn\u00edch faktor\u016f.<!– [et_pb_line_break_holder] –><\/p><!– [et_pb_line_break_holder] –><\/div>[\/et_pb_code][et_pb_text admin_label=“Human Testing – What We Know So Far“ module_class=“card card-primary“ text_text_color=“#000000″]<\/p>\n A\u010dkoli jsme ji\u017e d\u0159\u00edve hovo\u0159ili o testech na lidech, kter\u00e9 v sou\u010dasn\u00e9 dob\u011b prob\u00edhaj\u00ed, neprozradili jsme podrobn\u011b, co jsme dosud zjistili.<\/p>\n U\u010dinila tak v r\u00e1mci spole\u010dnosti „BioViva“, kter\u00e1 byla zalo\u017eena \u010dist\u011b za \u00fa\u010delem propagace t\u011bchto test\u016f ve snaze povzbudit ostatn\u00ed, aby za\u010dali testovat follistatin a dal\u0161\u00ed takzvan\u00e9 „anti-aging“ produkty.<\/p>\n Testy na zv\u00ed\u0159atech do t\u00e9 doby p\u0159inesly jen velmi m\u00e1lo konkr\u00e9tn\u00edch negativn\u00edch \u00fa\u010dink\u016f, s v\u00fdjimkou n\u011bkter\u00fdch definitivn\u00edch kardiovaskul\u00e1rn\u00edch poruch v ur\u010dit\u00fdch p\u0159\u00edpadech.<\/p>\n Je t\u0159eba poznamenat, \u017ee a\u010dkoli se jedn\u00e1 o pom\u011brn\u011b rizikov\u00fd prvek, kardiovaskul\u00e1rn\u00ed porucha rozhodn\u011b nen\u00ed nepravideln\u00e1 p\u0159i zav\u00e1d\u011bn\u00ed jak\u00e9hokoli anabolick\u00e9ho produktu, zejm\u00e9na pokud m\u00e1 hostitel z\u00e1kladn\u00ed genetick\u00e9 nedostatky.<\/p>\n Tento d\u016fvod by s\u00e1m o sob\u011b nem\u011bl b\u00fdt dostate\u010dn\u00fdm d\u016fvodem k tomu, aby se s testy na lidech ot\u00e1lelo po tak dlouhou dobu.<\/p>\n Proto je Elizabeth ke cti, \u017ee se pustila do pr\u00e1ce a poskytla n\u00e1m prvn\u00ed, velmi zaj\u00edmavou s\u00e9rii v\u00fdsledk\u016f t\u00fdkaj\u00edc\u00edch se dosavadn\u00edho u\u017e\u00edv\u00e1n\u00ed follistatinu.<\/p>\n A\u010dkoli je v\u00fdzkum st\u00e1le v po\u010d\u00e1tc\u00edch, zat\u00edm jsme dosp\u011bli k n\u00e1sleduj\u00edc\u00edm z\u00e1v\u011br\u016fm (alespo\u0148 v p\u0159\u00edpad\u011b Al\u017eb\u011bty):<\/p>\n \u25cf Pravd\u011bpodobn\u011b dojde k redukci tukov\u00e9 tk\u00e1n\u011b podko\u017en\u00ed i nitrobun\u011b\u010dn\u00e9 povahy Dal\u0161\u00ed podrobnosti o testu naleznete zde ve<\/a> spojen\u00ed s p\u0159esn\u00fdmi statistikami.<\/p>\n Pokud se uk\u00e1\u017ee, \u017ee v\u0161echny tyto prvky jsou spr\u00e1vn\u00e9, bude follistatin skute\u010dn\u011b mnohostrannou slou\u010deninou schopnou p\u0159in\u00e9st obrovsk\u00e9 v\u00fdsledky v mnoha oblastech.<\/p>\nTestov\u00e1n\u00ed na lidech – co zat\u00edm v\u00edme<\/h3>\n
Toto testov\u00e1n\u00ed za\u010dalo v roce 2015 d\u00edky 45let\u00e9 \u017een\u011b jm\u00e9nem Elizabeth Parrishov\u00e1; po letech stagnuj\u00edc\u00ed debaty o tom, zda jsme skute\u010dn\u011b p\u0159ipraveni zah\u00e1jit l\u00e9\u010dbu lidmi pomoc\u00ed follistatinu, Parrishov\u00e1 odv\u00e1\u017en\u011b ukon\u010dila diskuse t\u00edm, \u017ee se sama nominovala na prvn\u00ed osobu, kter\u00e1 provede strukturovan\u00fd v\u011bdeck\u00fd v\u00fdzkum t\u00e9to l\u00e1tky jako lidsk\u00fd hostitel.<\/p>\n
\u25cf M\u016f\u017ee se zlep\u0161it citlivost na inzul\u00edn
\u25cf M\u016f\u017ee se zlep\u0161it hustota a funk\u010dnost b\u00edl\u00fdch krvinek (a t\u00edm pos\u00edlit imunitn\u00ed syst\u00e9m)
\u25cf T\u00e9m\u011b\u0159 zaru\u010den\u00e9 je udr\u017een\u00ed svalov\u00e9 hmoty
\u25cf Pravd\u011bpodobn\u011b se sn\u00ed\u017e\u00ed hladina triglycerid\u016f v krvi
\u25cf M\u016f\u017ee se zlep\u0161it p\u0159\u00edjem \u017eivin.<\/p>\n